Advertisement

Mylan CEO Faces Questions Over EpiPen Price Surge03:47
Download

Play
Mylan Inc., which makes EpiPen, has come under fire from consumers and lawmakers for the price that it is currently charging. (Joe Raedle/Getty Images)
Mylan Inc., which makes EpiPen, has come under fire from consumers and lawmakers for the price that it is currently charging. (Joe Raedle/Getty Images)
This article is more than 4 years old.

Lawmakers in the House and Senate are introducing a bill today that would force drug makers to justify price hikes of more than 10 percent.

The move follows the disclosure this summer that Mylan's life-saving EpiPen now costs more than $600, six times higher than the price when the company acquired the drug in 2007. Mylan CEO Heather Bresch will testify on Capitol Hill next week.

Here & Now's Jeremy Hobson speaks with business journalist Ali Velshi about what may come from Congress on this issue.

Guest

Ali Velshi, business journalist. He tweets @AliVelshi.

This segment aired on September 15, 2016.

Related:

Advertisement

Advertisement